|
|
|
Volumn 26, Issue 4, 1999, Pages 938-944
|
|
International conference on systemic sclerosis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CORTICOSTEROID;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENDOTHELIN RECEPTOR ANTAGONIST;
METHOTREXATE;
NITRIC OXIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PENICILLAMINE;
PROSTACYCLIN DERIVATIVE;
RECOMBINANT RELAXIN;
VASODILATOR AGENT;
AUTOIMMUNE DISEASE;
BONE MARROW TRANSPLANTATION;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SCLERODERMA;
SYSTEMIC SCLEROSIS;
TREATMENT OUTCOME;
ANIMALS;
DISEASE MODELS, ANIMAL;
HUMANS;
RHEUMATOLOGY;
SCLERODERMA, SYSTEMIC;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 0032942227
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (0)
|
